ULTRAGENYX PHARMACEUTICAL IN

RARENASDAQ

🏆 #1684 by market capEarnings Nov 3US Equity

$777.49▼ $37.55 (−4.83%)

Simulated price

1h—

24h▼ 4.8%

7d—

14d—

30d—

1y—

🏦Market Cap

$2.61B

Small Cap

📈Revenue Growth (YoY)

+20.1%

Healthy

📊Gross Margin

83.1%

High

💵FCF Margin

-68.3%

Thin

⚖️P/S Ratio

3.6x

Fair

Otter Score

50

Weak

🔭

No analyst ratings for RARE

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.